The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Howell Peyton R since 2015.
This trader's CIK number is 1528056.
At the time of last reporting, Howell Peyton R was the Director of Tandem Diabetes Care Inc. (stock ticker symbol TNDM).
Also see all insider trading activities at Tandem Diabetes Care Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | TNDM | 0 | $0 | 0 | $0 | 4,387 | $90,547 |
| 2024 | TNDM | 0 | $0 | 0 | $0 | 4,434 | $229,370 |
| 2023 | TNDM | 3,000 | $90,492 | 0 | $0 | 3,706 | $0 |
| 2022 | TNDM | 2,000 | $149,722 | 0 | $0 | 2,602 | $0 |
| 2021 | TNDM | 0 | $0 | 0 | $0 | 948 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ABC | 0 | $0 | 26,851 | $2,422,020 | 26,851 | $1,571,724 |
| 2017 | ABC | 0 | $0 | 101,466 | $8,879,998 | 119,694 | $4,960,524 |
| 2016 | ABC | 0 | $0 | 48,750 | $4,375,800 | 48,750 | $1,433,493 |
| 2015 | ABC | 0 | $0 | 45,984 | $4,867,866 | 45,984 | $1,244,648 |
1. Tandem Diabetes Care Inc (TNDM)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-22 | TNDM | Option Ex | 4,387 | 20.64 | 90,547 |
| 2024-05-24 | TNDM | Option Ex | 4,434 | 51.73 | 229,370 |
| 2023-08-03 | TNDM | Option Ex | 949 | .00 | 0 |
| 2023-05-25 | TNDM | Option Ex | 2,757 | .00 | 0 |
| 2023-05-17 | TNDM | Buy | 3,000 | 30.16 | 90,492 |
| 2022-08-03 | TNDM | Option Ex | 949 | .00 | 0 |
| 2022-05-18 | TNDM | Option Ex | 1,653 | .00 | 0 |
| 2022-05-06 | TNDM | Buy | 2,000 | 74.86 | 149,722 |
| 2021-08-03 | TNDM | Option Ex | 948 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-04-04 | ABC | Sale | 3,000 | 82.72 | 248,160 |
| 2018-04-04 | ABC | Option Ex | 3,000 | 38.79 | 116,370 |
| 2018-03-01 | ABC | Option Ex | 17,851 | 68.49 | 1,222,614 |
| 2018-03-01 | ABC | Sale | 17,851 | 90.40 | 1,613,730 |
| 2018-02-07 | ABC | Option Ex | 3,000 | 38.79 | 116,370 |
| 2018-02-07 | ABC | Sale | 3,000 | 91.60 | 274,800 |
| 2018-01-08 | ABC | Option Ex | 3,000 | 38.79 | 116,370 |
| 2018-01-08 | ABC | Sale | 3,000 | 95.11 | 285,330 |
| 2017-12-14 | ABC | Option Ex | 17,800 | 68.49 | 1,219,122 |
| 2017-12-14 | ABC | Sale | 17,800 | 89.70 | 1,596,660 |
| 2017-12-06 | ABC | Option Ex | 3,000 | 38.79 | 116,370 |
| 2017-12-06 | ABC | Sale | 3,000 | 86.20 | 258,600 |
| 2017-11-30 | ABC | Option Ex | 9,423 | 40.21 | 378,898 |
| 2017-11-30 | ABC | Sale | 9,423 | 85.80 | 808,493 |
| 2017-11-08 | ABC | Sale | 3,000 | 74.87 | 224,610 |
| 2017-11-10 | ABC | Option Ex | 2,705 | .00 | 0 |
| 2017-11-08 | ABC | Option Ex | 3,000 | 38.79 | 116,370 |
| 2017-10-26 | ABC | Option Ex | 12,523 | 40.21 | 503,549 |
| 2017-10-24 | ABC | Option Ex | 3,000 | 38.79 | 116,370 |
| 2017-09-25 | ABC | Sale | 3,243 | 80.23 | 260,185 |
| 2017-09-25 | ABC | Option Ex | 3,243 | 38.79 | 125,795 |
| 2017-08-16 | ABC | Option Ex | 20,000 | 37.37 | 747,400 |
| 2017-08-16 | ABC | Sale | 20,000 | 80.00 | 1,600,000 |
| 2017-03-03 | ABC | Option Ex | 45,000 | 36.37 | 1,636,650 |
| 2017-03-03 | ABC | Sale | 45,000 | 91.81 | 4,131,450 |
| 2016-08-05 | ABC | Option Ex | 48,750 | 29.41 | 1,433,493 |
| 2016-08-05 | ABC | Sale | 48,750 | 89.76 | 4,375,800 |
| 2015-03-13 | ABC | Option Ex | 45,984 | 27.07 | 1,244,648 |
| 2015-03-13 | ABC | Sale | 45,984 | 105.86 | 4,867,866 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Howell Peyton R (Director of Tandem Diabetes Care Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.